Published in Biotechniques on November 01, 1995
The unfolded protein response sensor IRE1alpha is required at 2 distinct steps in B cell lymphopoiesis. J Clin Invest (2005) 3.16
The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med (2004) 1.92
Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A (2000) 1.13
Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1998) 1.13
RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice. Mol Cell Biol (2002) 1.00
Human bronchial epithelial and endothelial cells express alpha7 nicotinic acetylcholine receptors. Mol Pharmacol (2001) 1.89
Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol (1998) 1.56
Myasthenia in SCID mice grafted with myasthenic patient lymphocytes: role of CD4+ and CD8+ cells. Neurology (1999) 1.46
Human vascular endothelial cells express functional nicotinic acetylcholine receptors. J Pharmacol Exp Ther (1998) 1.45
A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol (1995) 1.35
Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. J Clin Invest (1997) 1.23
Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII. J Thromb Haemost (2003) 1.11
Mechanism of the immune response to human factor VIII in murine hemophilia A. Thromb Haemost (2001) 1.10
Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins. J Infect Dis (2000) 0.99
Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. J Immunol (2000) 0.95
Epitope repertoire of human CD4+ T cells on tetanus toxin: identification of immunodominant sequence segments. J Infect Dis (1997) 0.93
Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects. Thromb Haemost (2000) 0.92
Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII. J Thromb Haemost (2004) 0.91
T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects. J Thromb Haemost (2004) 0.90
Subcutaneous administration of T-epitope sequences of the acetylcholine receptor prevents experimental myasthenia gravis. J Neuroimmunol (1999) 0.89
CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects. Thromb Haemost (1999) 0.87
Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects. Eur J Immunol (1995) 0.86
Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis. Neurology (1997) 0.86
Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice. Scand J Immunol (1995) 0.85
T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology (1998) 0.84
Binding of native kappa-neurotoxins and site-directed mutants to nicotinic acetylcholine receptors. Toxicon (1997) 0.84
T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. J Neuroimmunol (2000) 0.83
CD4+ T cell repertoire on the epsilon subunit of muscle acetylcholine receptor in myasthenia gravis. J Neuroimmunol (1998) 0.81
Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the delta subunit. Muscle Nerve (2001) 0.81
Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor. J Neuroimmunol (1999) 0.81
Recognition of coagulation factor VIII by CD4+ T cells of healthy humans. J Thromb Haemost (2003) 0.81
CD4+ T cells specific for factor VIII as a target for specific suppression of inhibitor production. Adv Exp Med Biol (2001) 0.80
Expression of the alpha 7 subunit of the nicotinic acetylcholine receptor in normal and myasthenic human thymuses. Cell Mol Biol (Noisy-le-grand) (1997) 0.79
Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis. J Immunol (2001) 0.79
T cell recognition of the acetylcholine receptor in myasthenia gravis. Ann N Y Acad Sci (1998) 0.77
MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules. J Autoimmun (1996) 0.77
Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences. J Autoimmun (1996) 0.77
Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes. Eur J Immunol (1994) 0.77
TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients. J Autoimmun (1998) 0.77
TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis. J Autoimmun (1997) 0.76
Binding of monoclonal antibodies against the carboxyl terminal segment of the nicotinic receptor delta subunit suggests an unusual transmembrane disposition of this sequence region. Biochemistry (1995) 0.76
Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor. J Autoimmun (1998) 0.75
Binding of single substituted promiscuous and designer peptides to purified DRB1*0101. Biochem Biophys Res Commun (1998) 0.75
CD4+ epitope spreading and differential T cell recognition of muscle acetylcholine receptor subunits in myasthenia gravis. Ann N Y Acad Sci (1998) 0.75
Simple, inexpensive computerized rodent activity meters. Biotechniques (1995) 0.75
Clustering of B and T epitopes within short sequence regions of the nicotinic acetylcholine receptor. Scand J Immunol (1995) 0.75
Biosynthetic and synthetic AChR sequences to study T cells in myasthenia gravis. Ann N Y Acad Sci (1998) 0.75
Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis. Ann N Y Acad Sci (1998) 0.75
A T-linker strategy for modification and directional cloning of PCR products. Methods Mol Biol (1997) 0.75
Th1 cells of myasthenia gravis patients recognize multiple epitopes on the muscle acetylcholine receptor alpha subunit. Ann N Y Acad Sci (1998) 0.75
Rapid method for the elution and analysis of PCR products separated on high resolution acrylamide gels. Biotechniques (1995) 0.75
TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. J Autoimmun (1995) 0.75
Acetylcholine receptor-specific CD4+ T cells in myasthenia gravis patients have individual, but restricted TCR V beta usage. Ann N Y Acad Sci (1998) 0.75
Nasal administration of synthetic acetylcholine receptor T epitopes affects the immune response to the acetylcholine receptor and prevents experimental myasthenia gravis. Ann N Y Acad Sci (1998) 0.75
Designing PCR primers to amplify specific members or subgroups of multigene families. Methods Mol Biol (1997) 0.75
Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls. J Immunol (1995) 0.75
Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII. Hum Antibodies (2003) 0.75
Immunization of bm12 mice with high doses of acetylcholine receptor overcomes their resistance to experimental autoimmune myasthenia gravis. Ann N Y Acad Sci (1998) 0.75
TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans. J Autoimmun (1997) 0.75
Amino acids within residues 181-200 of the nicotinic acetylcholine receptor alpha1 subunit involved in nicotine binding. Biochem Pharmacol (1998) 0.75